Where Cells and Exosomes Come From: Sourcing, Isolation, and What the Method Tells You

isolation matter come from isolated and expanded exosomes come product cellGenic characterized professional frequently asked questions On this page Two vials can carry the same label and still differ a great deal. The difference usually starts well before the vial: with the tissue the cells came from, the way the donor was screened, and the […]

The Exosome Market in 2026: Supply, Standards and Where the Category Is Heading

market include forecasts tell us come from more important research and treatment market next exosome supplier can verify references On this page If you look inside your body right now, billions of microscopic messengers are moving back and forth between your cells. They are not cells themselves. Instead, they are tiny, fluid-filled sacs called exosomes. […]

Exosomes for Hair: What Providers Should Understand About the Evidence and the Regulatory Position

actually refers to currently shows category question Administration evaluating sourcing common questions regulatory disclaimer On this page Hair restoration is one of the more crowded corners of exosome literature. It’s also one of the more overstated. Search results and clinic marketing routinely present exosome therapy as a settled upgrade over platelet-rich plasma (PRP) and minoxidil […]

Exosomes, Growth Factors, Secretome, PDRN and Peptides: Sorting the Categories

Whole-Cell Product Single Compound Blurred Common questions On this page Five terms, one crowded supplier vocabulary, and an increasingly thin line between them in sourcing conversations. “Exosome,” “growth factor,” “secretome,” “PDRN,” and “peptide” show up constantly in the same paragraph, sometimes in the same sentence, as though they named one underlying material five different ways. […]

MSC, iPSC and Plant-Derived Exosomes: How the Source Changes the Product

Before Manufacturing Does Different Question Regulatory Posture Common Questions On this page Every exosome product on the market makes roughly the same claims about particle size, marker expression, and purity. What almost none of them lead with is the variable that actually determines what’s inside the vesicle: the source. Cargo, yield, batch-to-batch consistency, and regulatory […]

Exosomes vs Stem Cells: Why the Distinction Is Both Clinical and Legal

Data Actually Shows The Contamination Pathway Not a Settled One Common questions On this page A mesenchymal stem cell and an exosome derived from that same cell get discussed constantly as if they’re the same kind of research material. They aren’t. A cell is a living, replicating unit, capable of proliferation, differentiation, and, depending on […]

Exosome Safety: What the Published Literature Reports, and What It Does Not

Data Actually Shows The Contamination Pathway Not a Settled One Common questions References On this page Physicians evaluating exosome-based research material tend to start with mechanism and end with sourcing. Risk rarely gets the same rigor. Part of that is a supply problem: “exosomes side effects” returns almost nothing written for a clinical audience. Part […]

Exosomes vs PRP: What the Difference Means for Your Practice

Sourcing Divide Time and Staffing Batch Consistency Frequently Asked Questions References On this page For a practice weighing exosome-based protocols alongside PRP, the question that actually decides a purchase isn’t which one performs better. Neither product’s current evidence base is built to settle that question, and it isn’t the one a practice needs answered before […]

ROI of Adding Exosome & Peptide Products to Your Catalog

high margin all three Consolidation business case Frequently Asked Questions References On this page Every provider evaluating a new product line runs the same mental math: what’s the return, and how fast? For exosome and peptide products, the answer most content gives, “high margins, growing demand,” is true enough to be useless. It skips the […]

Exosomes vs Stem Cells vs PRP: A Provider Comparison

three categories provider actually compares the dividing line The comparison Frequently Asked Questions References The fast facts On this page Three options, three different categories, and a lot of content that blurs them together. When a provider is deciding what to add to a regenerative menu, the comparison that actually helps isn’t “which one works […]